Call for Applications: Executive Editor for Neuro-Oncology Advances
Dear EANO Members,
We are pleased to announce an exciting opportunity for the position of Executive Editor of Neuro-Oncology Advances (NOA), the official journal of the European Association of Neuro-Oncology (EANO) in partnership with the Society for Neuro-Oncology (SNO). Following the recent appointment of Professor Wolfgang Wick as Editor-in-Chief, the position of Executive Editor for EANO has become available.
In a team of 3 Executive Editors and 22 Associate Editors together with an excellent Editorial Office (Dr. Elizabeth Martinson) you will be responsible for the scientific and structural development of the journal. This is involving handling manuscripts, developing ideas for featured content and formats, as well as contact to the editorial board and the neuro-oncology community.
We are seeking an established and dynamic clinical and/or preclinical researcher with the following qualifications:
- Experience in editorial roles, particularly in reviewing and managing scientific content
- A strong track record of published research in neuro-oncology
- A passion for advancing neuro-oncology research and fostering collaborations
- Must be an
EANO Member
Key Information:
- Position Start Date: March 2026
- Duration of the Position: 7 years
- Reimbursement: This is a non-remunerated position
- Application Deadline: September 21, 2025
- Application Requirements:
- A motivational letter outlining your interest and vision for the role
- A concise CV (maximum 2 pages)
Please send your application materials to the EANO Office at office@eano.eu by the stated deadline. A Search Committee will review all applications and nominate a successful candidate to the EANO Board from the pool of applicants.
This is a unique opportunity to contribute to the global neuro-oncology community and influence the future of research and treatment in this critical field. We look forward to receiving your applications.
Warm regards,
Norbert Galldiks
Chair, EANO Publishing Activity Committee
Michael Platten
President, EANO
About the journal Neuro-Oncology Advances
Neuro-Oncology Advances (NOA) was launched in 2019 as the first open-access journal published by OUP in partnership with the Society for Neuro-Oncology (SNO) and the European Association of Neuro-Oncology (EANO). Its aim is to ensure that research and discoveries in the field are accessible to a broader readership and retained within the wider neuro-oncology community. NOA is an inter-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neuroradiologists, and researchers together with educators. In 2024, the Impact Factor of the journal increased to 4.1.
EANO Mentorship Program: Call for Mentees now open!
EANO invites you to take part in our Mentorship Program—a unique opportunity to grow, connect, and develop your own project with the support of an experienced mentor.
Whether you're a basic scientist, clinician, or allied health professional, this program is designed to help you gain new skills, from setting up a research project to writing a grant or manuscript.
You’ll be matched with a mentor for one year, with monthly virtual check-ins to guide your progress.
All mentees must be EANO members and will complete a short mid-term update and a final project summary. Take the next step in your neuro-oncology journey—apply now!
For more information about the program and how to apply, please click here.
Application deadline: Wednesday, August 27, 2025.
Multidisciplinary management of patients with glioma

This interactive event, taking place a day prior to the EANO 2025 Meeting in Prague, aims to promote the multidisciplinary management of glioma patients an essential approach to ensuring timely, appropriate treatment and maximizing both survival and quality of life.
The program consists of three multidisciplinary case-based discussions around the management of patients with glioma, combined with short lectures focusing on the practical aspects, emphasizing the evidence base that underpins management decisions. Case discussions will be led by a multidisciplinary panel of experts, with the audience encouraged to participate in the discussion.
The event is aimed at residents, medical specialists, and nurses working in the field of neuro-oncology.
For full program, please follow the link HERE.
Time & date: Wednesday, October 15, 2025, from 13:00 to 16:00 CEST
Where: Prague, Czech Republic
Venue: Prague Congress Centre, 5. kvetna 1640/65, Nusle, 140 21 Prague 4, CZ
Registration fee: Free for all EANO Members
Registration deadline: Friday, October 3, 2025, 23:59 CESTREGISTER HERE
Why Become an EANO Member?
EANO is Europe’s multidisciplinary Neuro-Oncology organisation representing all medical and scientific disciplines involved in the prevention, diagnosis and treatment of tumours of the central nervous system (CNS). EANO is dedicated to promote advances in Neuro-Oncology through innovative research and concerted education and training. It enhances collaboration between all relevant disciplines - Neuro-Oncology, Neurosurgery, Neuropathology, Neuroradiology, and Radiation Oncology as well as Nursing - and aims at bridging science, knowledge and practice gaps in the management of CNS malignancies.
Today, EANO has over 700 members from more than 70 countries. EANO stimulates (inter)national cooperation together with our major partner societies, the Society of Neuro-Oncology in the US (SNO) and the Asian Society of Neuro-Oncology (ASNO); together, EANO, SNO and ASNO are charter societies of the World Federation of Neuro-Oncology Societies (WFNOS).
The EANO Youngster Initiative provides a platform for exchange, networking and career support for young clinicians and scientists.
EANO provides multiple services to its members. We organise scientific and educational webinars and meetings with 'state of the art' lectures covering the broad spectrum of all disciplines in Neuro-Oncology, including our flagship annual EANO Meeting and the quadrennial WFNOS Meeting.
Further, EANO offers exclusively to its members free access to Neuro Oncology, Neuro Oncology Practice and the Neuro Oncology Advances Journals.
EANO considers the preparation of multidisciplinary guidelines as a prime task to support the development of high quality care for brain tumour patients across Europe. The EANO Youngster Initiative is a highly active platform for exchange, networking and career support for young clinicians and scientists. We also offer high level post-graduate education through the EANO School of Neuro-Oncology launched in 2022 and strongly support increasing diversity in the Neuro-Oncology community.
Kind Regards
Michael Platten
EANO President (2024-2026)